Sign inGet started

Fishman Mark

Insider CIK 1786003 · BEAM Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
BEAM Beam Therapeutics Inc. A Award deriv2026-06-032026-06-0519,676— $019,676SEC↗
BEAM Beam Therapeutics Inc. A Award deriv2025-06-042025-06-0633,662— $033,662SEC↗
BEAM Beam Therapeutics Inc. A Award deriv2024-06-052024-06-0723,114— $023,114SEC↗
BEAM Beam Therapeutics Inc. A Award deriv2023-06-062023-06-0816,532— $016,532SEC↗
BEAM Beam Therapeutics Inc. A Award deriv2022-09-012022-09-0210,391— $010,391SEC↗
BEAM Beam Therapeutics Inc. A Award deriv2021-06-102021-06-146,877— $06,877SEC↗
BEAM Beam Therapeutics Inc. C Conversion deriv2020-02-102020-02-111,239— $00SEC↗
BEAM Beam Therapeutics Inc. C Conversion deriv2020-02-102020-02-1115,768— $00SEC↗
BEAM Beam Therapeutics Inc. C Conversion2020-02-102020-02-1117,007— $017,007SEC↗